Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Alx Oncology Holdings (ALXO) Accumulated Depreciation & Amortization (2019 - 2026)

Alx Oncology Holdings' Accumulated Depreciation & Amortization history spans 5 years, with the latest figure at $800000.0 for Q4 2023.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 166.67% to $800000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $800000.0, a 166.67% increase, with the full-year FY2023 number at $800000.0, up 166.67% from a year prior.
  • Accumulated Depreciation & Amortization hit $800000.0 in Q4 2023 for Alx Oncology Holdings, up from $200000.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for ALXO hit a ceiling of $800000.0 in Q4 2023 and a floor of $30000.0 in Q1 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $217235.3 across 5 years, with a median of $200000.0 in 2019.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: tumbled 70.0% in 2021 and later skyrocketed 566.67% in 2022.
  • Tracing ALXO's Accumulated Depreciation & Amortization over 5 years: stood at $400000.0 in 2019, then crashed by 50.0% to $200000.0 in 2020, then plummeted by 68.5% to $63000.0 in 2021, then surged by 376.19% to $300000.0 in 2022, then skyrocketed by 166.67% to $800000.0 in 2023.
  • Business Quant data shows Accumulated Depreciation & Amortization for ALXO at $800000.0 in Q4 2023, $200000.0 in Q3 2023, and $200000.0 in Q2 2023.